Freeha Arshad

Superior University — Pakistan

Medicine · Health Sciences

7h-index437citations18works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease and Transplantation(11), Organ Transplantation Techniques and Outcomes(6), Liver Disease Diagnosis and Treatment(4), Blood Coagulation and Thrombosis Mechanisms(4), Trauma, Hemostasis, Coagulopathy, Resuscitation(4)

Publications18 total

The role of big data analytics in the footwear supply chains: a multiple case study perspective
Journal of Science and Technology Policy Management·2024· 1 cited
Blood Markers of Portal Hypertension Are Associated with Blood Loss and Transfusion Requirements during Orthotopic Liver Transplantation
Seminars in Thrombosis and Hemostasis·2020· 10 citedOpen Access
Raw data for Version 2 of "Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation"
Figshare·2019Open Access
Pathophysiology and management of hemostatic alterations in cirrhosis and liver transplantation
University of Groningen research database (University of Groningen / Centre for Information Technology)·2016· 2 citedOpen Access
Database containing demographic data of each patient and laboratory data of each patient and control
Figshare·2015· 1 citedOpen Access
Infusion of <scp>DDAVP</scp> does not improve primary hemostasis in patients with cirrhosis
Liver International·2014· 38 citedOpen Access
Infusion of DDAVP Does Not Improve Primary Hemostasis in Patients with Cirrhosis
Blood·2014· 5 cited
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation
F1000Research·2014· 5 citedOpen Access
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation
F1000Research·2014· 2 citedOpen Access
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation
F1000Research·2014· 6 citedOpen Access
Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis
PLoS ONE·2014· 97 citedOpen Access
Database containing demographic data of each patient and laboratory data of each patient and control
Figshare·2014· 1 citedOpen Access
Routine coagulation assays underestimate levels of antithrombin‐dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis
British Journal of Haematology·2013· 83 citedOpen Access
Decreased tissue factor pathway inhibitor (<scp>TFPI</scp>)‐dependent anticoagulant capacity in patients with cirrhosis who have decreased protein <scp>S</scp> but normal <scp>TFPI</scp> plasma levels
British Journal of Haematology·2013· 22 cited
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial
BMC Surgery·2013· 76 citedOpen Access
Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient
Liver International·2013· 86 cited
Physiology, Prevention, and Treatment of Blood Loss During Liver Transplantation
2012· 1 cited
Increase in RBC Transfusion Requirements during Orthotopic Liver Transplantation after Market Withdrawal of Aprotinin.
Data Archiving and Networked Services (DANS)· 1 cited

Frequent Co-authors

Robert J. Porte(15), Ton Lisman(15), Jelle Adelmeijer(10), Hans Blokzijl(10), A. P. van den Berg(5), Wilma Potze(3), Aad van den Berg(3), Joost C.M. Meijers(2), Sara C. M. Stoof(2), Frank W.G. Leebeek(2), Karin Ruitenbeek(2), Marieke J.H.A. Kruip(2), Aad P. van den Berg(2), Brigitte Ickx(1), Rachel T. van Beem(1), Wojciech G. Polak(1), Frank Grüne(1), Frederik Nevens(1), Minna Ilmakunnas(1), Anna‐Maria Koivusalo(1)